Bowel disease breakthrough as researchers make ‘holy grail’ discovery

Scientists pinpoint driver of IBD and other disorders with work under way to adapt existing drugs to treat patients

Researchers have discovered a major driver of inflammatory bowel disease (IBD) and several other immune disorders that affect the spine, liver and arteries, raising hopes for millions of people worldwide.

The breakthrough is particularly exciting because the newly found biological pathway can be targeted by drugs that are already used, with work under way to adapt them to patients with IBD and other conditions.

Continue reading...

Combining three healthy behaviours can lower IBS risk, study finds

People who tick at least three out of five boxes including not smoking and good sleep are found to have 42% lower risk

Combining three healthy behaviours can reduce the risk of irritable bowel syndrome by 42%, a study suggests.

IBS affects the digestive system and its symptoms include stomach cramps, bloating, diarrhoea and constipation. People can suffer for days, weeks or months at a time, and symptoms can come and go. IBS is thought to affect up to one in 10 people worldwide.

Continue reading...